Research Article

An Audit of CT Chest Reports and Their Potential Impact on the Workup of Patients with Suspected Lung Cancer

Table 2

Additional imaging studies and invasive testing suggested in CT reports.

Total N = 146

Additional imaging studies suggested in CT reports
No recommendation, N (%)122 (83)
Guideline-concordant suggestion, N (%)17 (12)
PET/CT9
Abdominal imaging (US/MRI/CT)5
Bone scan2
Abdominal imaging and bone scan1
Guideline-discordant suggestion, N (%)7 (5)
Follow-up CT nodule >8 mm ± lymphadenopathy7

Invasive testing suggested in CT reports
No recommendation, N (%)115 (79)
Guideline concordant testing, N (%)18 (12)
TTNA: nodule (Tx/N0/M0)7
TTNA: mediastinal mass (Tx/N1-3/M0)1
Bronchoscopy (Tx/Nx/M1)4
Tissue sampling, not specified (Tx/N0/M0) 6
Guideline discordant testing, N (%)13 (9)
TTNA. nodule (Tx/N1-3/M0)4
TTNA, nodule (Tx/Nx/M1)4
Bronchoscopy (Tx/Nx/M1)2
Tissue sampling, not specified (Tx/N1-3/M0) 2
Tissue sampling, not specified (Tx/Nx/M1)1

Bronchoscopy was considered guideline-concordant in the presence of widely metastatic disease and endobronchial disease. Similarly, tissue sampling, not specified, was considered concordant in the presence of only one potential biopsy site. Bronchoscopy was considered guideline-discordant in the presence of an otherwise easily accessible biopsy site (e.g., nodes accessible with endoscopic ultrasound or accessible metastatic site) and no clear endobronchial disease. Similarly, tissue sampling, not specified, was considered guideline-discordant in the absence of a clear recommendation to target a specific, accessible biopsy site.